The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 251.00
Bid: 249.00
Ask: 251.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.803%)
Open: 250.00
High: 254.00
Low: 248.50
Prev. Close: 251.00
CSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on AGM Voting

15 Nov 2023 07:00

RNS Number : 4553T
Chesnara PLC
15 November 2023
 

 

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

15th November 2023

 

CHESNARA plc

("Chesnara", the "Company" or the "Group")

 

RESPONSE TO VOTING RESULTS AT 2023 ANNUAL GENERAL MEETING

 

In accordance with Provision-4 of the UK Corporate Governance Code, Chesnara (CSN.L), the European life insurance consolidator, today provides an update to our statement of 16th May 2023 regarding the result of the poll vote at the 2023 Annual General Meeting ("AGM") on Resolution-2 to approve the Directors' Remuneration Report.

 

Resolution-2 passed with 72.66% of votes in favour. Since the AGM, the Remuneration Committee has engaged with the Company's major shareholders and proxy agencies to help understand the reasons for votes cast against Resolution-2. Three areas have been identified, which are in line with those raised by proxy investor bodies in their respective reports published just in advance of the 2023 AGM. We set them out below, alongside the proposed response to each.

 

 

LTIP to be Based One Third on Surplus Emergence

 

One area of feedback related to the use of cash generation metrics in both the Short Term Incentive Scheme ("STIS") and Long Term Incentive Plan ("LTIP"). In response to this, for LTIP awards granted in FY24, the Commercial Cash Generation metric will be replaced by a new Surplus Emergence metric. The existing relative TSR and Economic Value growth metrics will be retained. Each metric will be weighted one third of the assessment in line with the current approach.

 

Surplus Emergence will be one of the Group's KPIs and will be consistent with the definition used for reporting elsewhere in the annual report and the Company's other trading updates. It represents the operational surplus that has been generated in the period, largely a function of the movement in the solvency position of the insurance subsidiaries within the Group and takes account of the buffers that management has set to hold over and above the solvency requirements imposed locally by our regulators.

 

 

All LTIP Performance Targets to be Disclosed Prospectively

 

Shareholders expressed a preference for LTIP performance targets to be disclosed prospectively, in line with the approach the Company has always taken for the relative TSR metric. The Company acknowledges that this is increasingly common practice and going forward will disclose threshold targets prospectively going forwards, commencing with the targets for the LTIP awards to be granted in 2024.

 

 

Assessment of the Company's M&A Activity Within the Strategic Scorecard of the STIS

 

For 2024, the Remuneration Committee is proposing to make a small modification to the performance measures to be included in the STIS. The Strategic Scorecard (30% weighting) will be replaced by an ESG metric (5% weighting) and a Strategic Activity Scorecard (25% weighting) which focuses on the assessment of value-enhancing strategic activities including M&A, management actions, operational programme delivery and pipeline development. The weightings within the Strategic Activity Scorecard will vary year-to-year to reflect the relative priorities for the Company.

 

This means the assessment of M&A activity for the FY24 STIS will be entirely contained within the Strategic Activity Scorecard with no discretion applied. Full details of the assessment of the Strategic Activity Scorecard will be included in the Directors' Remuneration Report each year.

 

 

 

 

 

The Remuneration Committee would like to thank the major shareholders who have engaged in the consultation exercise since the AGM and believes that the proposed changes address the key issues raised. In accordance with the Corporate Governance Code, a final summary will be provided in the Company's 2023 Annual Report.

 

 

 

For further information, please contact:

 

Investor Enquiries

Sam Perowne

Head of Strategic Development & Investor Relations

Chesnara plc

E - sam.perowne@chesnara.co.uk

 

Media Enquiries

Roddy Watt

Director, Capital Markets

FWD

T - 020 7280 0651 / 07714 770 493 

E - roddy.watt@fwdconsulting.co.uk

 

 

Notes to Editors

Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured and CASLP in the UK, as The Waard Group and Scildon in the Netherlands and as Movestic in Sweden.

 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 18 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMNKQBDFBDDODD
Date   Source Headline
1st May 20207:00 amRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSHolding(s) in Company
29th Apr 20207:00 amRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSBlock listing Interim Review
23rd Apr 20207:00 amRNSNotice of AGM
15th Apr 20204:00 pmRNSHolding(s) in Company
15th Apr 20207:00 amRNSFinal Results
6th Apr 20203:54 pmRNSHolding(s) in Company
30th Mar 20207:00 amRNSTrading Statement
23rd Mar 20207:15 amRNSNotice of Results
20th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20207:00 amRNSNotice of Results
14th Feb 20207:00 amRNSDirectorate Change
17th Dec 20197:00 amRNSChange of Adviser
22nd Nov 20197:00 amRNSAcquisition
25th Oct 20197:00 amRNSBlock listing Interim Review
22nd Oct 20195:11 pmRNSHolding(s) in Company
22nd Oct 20195:11 pmRNSHolding(s) in Company
2nd Oct 20195:11 pmRNSHolding(s) in Company
30th Sep 20195:00 pmRNSTotal Voting Rights
30th Sep 20192:33 pmRNSHolding(s) in Company
20th Sep 20199:00 amRNSHolding(s) in Company
19th Sep 20195:00 pmRNSHolding(s) in Company
12th Sep 20195:24 pmRNSHolding(s) in Company
9th Sep 20192:11 pmRNSDirector/PDMR Shareholding
2nd Sep 20197:00 amRNSDirector/PDMR Shareholding
29th Aug 20197:00 amRNSHalf-year Report
6th Aug 20194:40 pmRNSNotice of Results
31st Jul 20197:00 amRNSTotal Voting Rights
31st May 20197:00 amRNSTotal Voting Rights
29th May 20197:00 amRNSDirector/PDMR Shareholding
14th May 20192:34 pmRNSResult of AGM
7th May 20191:23 pmRNSHolding(s) in Company
30th Apr 20197:00 amRNSDirector/PDMR Shareholding
25th Apr 20197:00 amRNSBlock listing Interim Review
16th Apr 20197:00 amRNSNotice of AGM
12th Apr 201910:17 amRNSHolding(s) in Company
29th Mar 20197:00 amRNSFinal Results
15th Mar 20197:00 amRNSNotice of Results
31st Dec 20187:00 amRNSTotal Voting Rights
17th Dec 20185:36 pmRNSDirectorate Change
13th Dec 20189:30 amRNSDirector/PDMR Shareholding
12th Dec 20187:00 amRNSHolding(s) in Company
30th Nov 20187:00 amRNSTotal Voting Rights
6th Nov 20188:27 amRNSDirector/PDMR Shareholding
25th Oct 20187:00 amRNSBlock listing Interim Review
1st Oct 20187:00 amRNSNew Senior Independent Director
30th Aug 20187:00 amRNSHalf-year Report
6th Aug 20183:37 pmRNSNotice of H1 Results
10th Jul 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.